biotech · Breast Cancer · Sarcoma,Soft Tissue · INTS
INTENSITY THERAPEUTICS
INTENSITY THERAPEUTICS, INC.
INTENSITY THERAPEUTICS clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Shelton, USA
- Founded
- 2012
- Employees
- 12
- Programs
- 6
- Drugs
- 9
- Patents
- 3
INTENSITY THERAPEUTICS projects
6 ClinicalTrials.gov programs sponsored by INTENSITY THERAPEUTICS.
INTENSITY THERAPEUTICS has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
INT230-6
INTENSITY THERAPEUTICS, INC.
Sarcoma,Soft Tissue
1 trial -
IT-03
INTENSITY THERAPEUTICS, INC.
liposarcoma (dedifferentiated, myxoid, round cell or pleomorphic), Leiomyosarcoma (non-uterine), Undifferentiated pleomorphic sarcoma
1 trial -
INT230-6
INTENSITY THERAPEUTICS, INC.
Breast Cancer
2 trials -
JIN-A02
INTENSITY THERAPEUTICS, INC.
EGFR Mutant Advanced Non-small Cell Lung Cancer
1 trial -
MPT0B640
INTENSITY THERAPEUTICS, INC.
Advanced Solid Tumor
1 trial -
MPT0B640
INTENSITY THERAPEUTICS, INC.
Covid19
1 trial
Frequently asked questions
How many clinical projects does INTENSITY THERAPEUTICS have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.